SUSRF (Surgical Science Sweden AB) Quick Ratio: 3.66 (As of Mar. 2026) — 12% Above Median


SUSRF Surgical Science Sweden AB SUSRF
82 GF Score
Price $4.00
GF Value $14.30
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Surgical Science Sweden AB Quick Ratio?

Surgical Science Sweden AB SUSRF -2.20% 82 Quick Ratio is 3.66 as of Mar. 2026, which is 12% above its 10-year median of 3.26. GuruFocus rates SUSRF with a GF Score™ of 82/100 and a GF Value™ of $14.30 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Surgical Science Sweden AB ranks better than 83.46% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Surgical Science Sweden AB's quick ratio for the quarter that ended in Mar. 2026 was 3.66.

Surgical Science Sweden AB has a quick ratio of 3.66. It generally indicates good short-term financial strength.

The historical rank and industry rank for Surgical Science Sweden AB's Quick Ratio or its related term are showing as below:

SUSRF' s Quick Ratio Range Over the Past 10 Years
Min: 0.86   Med: 3.26   Max: 5.28
Current: 3.66

During the past 11 years, Surgical Science Sweden AB's highest Quick Ratio was 5.28. The lowest was 0.86. And the median was 3.26.

SUSRF's Quick Ratio is ranked better than
83.46% of 683 companies
in the Healthcare Providers & Services industry
Industry Median: 1.32 vs SUSRF: 3.66

Surgical Science Sweden AB  (OTCPK:SUSRF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Surgical Science Sweden AB Quick Ratio Related Terms


Surgical Science Sweden AB Quick Ratio Historical Data

* Premium members only.

The historical data trend for Surgical Science Sweden AB's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Science Sweden AB Quick Ratio Chart

Surgical Science Sweden AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.17 2.26 3.56 2.43 3.34

Surgical Science Sweden AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.23 3.32 3.42 3.34 3.66

SUSRF vs VEEV, BTSG, TEM: Quick Ratio Comparison

For the Health Information Services subindustry, Surgical Science Sweden AB's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Science Sweden AB Quick Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgical Science Sweden AB's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Surgical Science Sweden AB's Quick Ratio falls into.


SUSRF
82GF Score
Surgical Science Sweden AB SUSRF
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surgical Science Sweden AB Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Surgical Science Sweden AB's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(127.475-22.163)/31.502
=3.34

Surgical Science Sweden AB's Quick Ratio for the quarter that ended in Mar. 2026 is calculated as

Quick Ratio (Q: Mar. 2026 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(127.354-22.27)/28.701
=3.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 3.66 mean?
Surgical Science Sweden AB (SUSRF) has a Quick Ratio of 3.66 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Surgical Science Sweden AB and its competitors. This is 12% above median its historical median of 3.26. Over the past decade, Surgical Science Sweden AB's Quick Ratio has ranged from 0.86 to 5.28. According to the industry distribution chart, Surgical Science Sweden AB ranks #113 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 16.5%.
Is Surgical Science Sweden AB's Quick Ratio too high?
Surgical Science Sweden AB's current Quick Ratio of 3.66 is 12% above median its 10-year median of 3.26. Over the past 10 years, this metric has ranged from a low of 0.86 to a high of 5.28. The Healthcare Providers & Services industry median Quick Ratio is 1.32. Surgical Science Sweden AB's value of 3.66 is 177.3% above this industry median. Based on the distribution chart, Surgical Science Sweden AB ranks #113 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Surgical Science Sweden AB has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Surgical Science Sweden AB's Quick Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Surgical Science Sweden AB ranks #113 out of 683 companies for Quick Ratio. This places Surgical Science Sweden AB in the top 17% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.32. Surgical Science Sweden AB's value of 3.66 is 177.3% above this benchmark. Historically, Surgical Science Sweden AB's own Quick Ratio has ranged from 0.86 to 5.28 over the past decade. While the company's 10-year median is 3.26 vs. the industry median of 1.32, Surgical Science Sweden AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Healthcare Providers & Services company?
The median Quick Ratio among Healthcare Providers & Services companies is 1.32, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surgical Science Sweden AB's current Quick Ratio of 3.66 is 177.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Surgical Science Sweden AB and its competitors. For the Healthcare Providers & Services industry, the median Quick Ratio is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surgical Science Sweden AB's current Quick Ratio is 3.66, which is 12% above median its own 10-year median of 3.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Science Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Surgical Science Sweden AB (SUSRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.30, compared to a current price of $4.00 — trading 72% below its estimated fair value. The current Quick Ratio is 3.66, which is 12% above median its 10-year median of 3.26 and 177.3% above the Healthcare Providers & Services industry median of 1.32. Surgical Science Sweden AB's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Surgical Science Sweden AB (SUSRF), the current Quick Ratio is 3.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgical Science Sweden AB (SUSRF) Overvalued in 2026?

Based on GuruFocus' analysis, Surgical Science Sweden AB stock appears to be undervalued. The current stock price of $4.00 is trading 72% below its estimated GF Value™ of $14.30. GuruFocus considers Surgical Science Sweden AB to be Significantly Undervalued.

Key valuation signals for SUSRF:

  • Quick Ratio: 3.66 (12% above median its 10-year median of 3.26)
  • GF Value™: $14.30 vs. price of $4.00 (72% below fair value)
  • GF Score™: 82/100 with 4 warning signs
  • Industry Position: 177.3% above the Healthcare Providers & Services median (#113 of 683)

No single metric tells the full story. See the SUSRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Surgical Science Sweden AB Business Description

Other Exchanges SUS:Sweden4P41:Germany
Address Drakegatan 7A, Gothenburg, SWE, SE-412 50
Surgical Science Sweden AB is a supplier of virtual reality simulators for medical training. The company's core is its proprietary software and hardware for simulating interactions between instruments and anatomy. It has two operating segments: Educational products include Proprietary brand medical simulator hardware and software for generic training of psycho-motor skills, instrument handling, and training for a large number of procedures and examinations prior to entering the clinical environment, as well as support and services. Industry/OEM includes simulation software for product-specific training of surgeons in robot-assisted surgery and other digitalized medical instruments, and also simulators for medical device companies.
82GF Score

Get the complete analysis for SUSRF

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.00
Price
$14.30
GF Value